Kathy Neuzil

Kathy Neuzil leads our work in vaccine access and delivery. Photo: PATH.

Program Leader, Vaccine Access and Delivery

Kathy Neuzil, MD, MPH, directs PATH’s activities in vaccine access and delivery, which focus on developing and advancing strategies, technologies, and interventions that help move research achievements in immunization into routine use in the field. Since joining PATH in 2005, Dr. Neuzil has provided strategic leadership, direction, and technical guidance for a variety of vaccine projects and studies, including work on vaccines against rotavirus, HPV, Japanese encephalitis, and influenza.

Prior to joining PATH, Dr. Neuzil held academic positions at the University of Washington and Vanderbilt University, where she led research projects on a variety of viral and bacterial vaccines, including influenza, respiratory syncytial virus, pneumococcus, and varicella-zoster virus. She retains a clinical professorship in medicine and global health at the University of Washington and has contributed more than 100 scientific papers on vaccines and infectious diseases.

Dr. Neuzil has extensive experience in domestic and international policy, including membership on the Centers for Disease Control Advisory Committee on Immunization Practices and the Pandemic Influenza Task Force for the Infectious Disease Society of America. Dr. Neuzil has worked with the World Health Organization as a technical advisor on diarrheal diseases, member of the Strategic Advisory Group of Experts rotavirus vaccine working group, and member of the Global Advisory Committee on Vaccine Safety working group on the safety of vaccines in pregnancy.

Dr. Neuzil received her BS in zoology from the University of Maryland, her MD from Johns Hopkins University School of Medicine, and her MPH from Vanderbilt University. She received her training in internal medicine and infectious diseases at Vanderbilt University.